Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) (Middle Region) Peptide
SART3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SART3 products
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SART3 antibody (Catalog #: ARP34329_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) peptide
SART3 Reactivity: Human Host: Synthetic BP, Imm
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Synonyms
- SART3 Peptide, DKFZp469J2418 Peptide, si:ch211-191d15.4 Peptide, wu:fc51h03 Peptide, DSAP1 Peptide, P100 Peptide, RP11-13G14 Peptide, TIP110 Peptide, p110 Peptide, p110(nrb) Peptide, AU045857 Peptide, mKIAA0156 Peptide, squamous cell carcinoma antigen recognized by T-cells 3 Peptide, squamous cell carcinoma antigen recognized by T-cells 3 L homeolog Peptide, squamous cell carcinoma antigen recognized by T cells 3 Peptide, SART3 Peptide, sart3 Peptide, sart3.L Peptide, Sart3 Peptide
- Background
-
SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing. The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: KIAA0156, MGC138188, RP11-13G14, TIP110, p110(nrb), P100, p110, DSAP1
Protein Interaction Partner: AR,COIL,MEGF10,PRPF3,RNPS1,AR,C3orf17,C3orf26,CDK9,DDX47,FRG1,LSM2,LSM4,LSM6,LSM7,MEPCE,MLF1IP,NAA38,PPIH,PRPF3,PRPF31,PRPF4,RNPS1,RPF2,RRP15,SNRPB,SRBD1,TUT1,USP15,USP39,USP4
Protein Size: 963 - Molecular Weight
- 110 kDa
- Gene ID
- 9733
- NCBI Accession
- NM_014706, NP_055521
- UniProt
- Q15020
-
You are here:
